Women's Health Market 2024-2033 : Industry Analysis, Size, Share, Growth And Forecast | AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc.

"The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company presents an extensive market research report on the Women's Health Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.

Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.

Market Sizing:

The women's health market size has grown steadily in recent years. It will grow from $41.22 billion in 2023 to $43.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to advancements in reproductive medicine, awareness and education initiatives, empowerment and advocacy movements, prenatal and postnatal care advances, development of hormone replacement therapies..

The women's health market size is expected to see strong growth in the next few years. It will grow to $53.69 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to precision medicine in gynecology, rise in female-focused clinical trials, expanded use of non-invasive prenatal testing, expanded access to fertility treatments, increasing focus on mental health.. Major trends in the forecast period include digital health solutions, fertility tracking and reproductive health, non-hormonal contraceptive options, maternal health and pregnancy monitoring, innovations in women's health diagnostics, integration of artificial intelligence (ai)..

Request for free sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

Key Market Players:

Major companies operating in the women's health market report are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Allergan Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Siemens AG, Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Oviva Therapeutics Inc., Samphire Neuro Inc., Scailyte AG, Syrona Health AG

Market Drivers:

The rising prevalence of women-centric diseases is expected to propel the growth of the women's health market going forward. The women-centric diseases such as anemia, osteoporosis, breast cancer, menopause, and others are highly occurring due to various risk factors such as family history, increasing age, early onset of periods or menopause after 55 years, obesity, and others. This rising prevalence of women-centric diseases drives demand for women's health products and services that are required to treat these diseases and ensure the health and wellness of women. For instance, American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer published an article in January 2023, according to which, cervical cancer was once one of the most common causes of cancer death for American women. About 13,960 new cases of invasive cervical cancer will be diagnosed in the USA in 2023 and from that around 4,310 women is expected to die from cervical cancer. Therefore, the rising prevalence of women-centric diseases is driving the growth of the women's health market.

Learn More About The Market Report -
https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

The women's health market covered in this report is segmented -

1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline
2) By Age: 50 Years & above , Other Ages
3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries
4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The report answers the following questions:
What are the primary factors propelling the market during the projected period?

In which region is the most substantial growth expected?

Which trend will take center stage in the upcoming period?

Want To Know More About The Business Research Company?

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.